# COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial Infarction

Study · id `cardio:ct-nct03156816` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03156816](<https://clinicaltrials.gov/study/NCT03156816>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03156816

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 194 participants.

## Technical summary

Registry record NCT03156816. Randomized; quadruple masking; primary purpose treatment. Start 2018-07-23 (actual); primary completion 2020-11-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 194 participants (enrolled count; ClinicalTrials.gov record NCT03156816, source copy `cardio:ctgov-nct03156816-2025-08-01`, retrieved 2026-10-26)
- Started: 2018-07-23 (actual) (ClinicalTrials.gov record NCT03156816, source copy `cardio:ctgov-nct03156816-2025-08-01`, retrieved 2026-10-26)
- Primary completion: 2020-11-08 (actual) (ClinicalTrials.gov record NCT03156816, source copy `cardio:ctgov-nct03156816-2025-08-01`, retrieved 2026-10-26)
- Completion: 2021-08-16 (actual) (ClinicalTrials.gov record NCT03156816, source copy `cardio:ctgov-nct03156816-2025-08-01`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT03156816, source copy `cardio:ctgov-nct03156816-2025-08-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03156816-2025-08-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial Infarction
- Acronym: COVERT-MI
- Condition: Myocardial Infarction
- Intervention (Drug): Colchicine group (experimental arm)
- Intervention (Drug): Placebo group (control arm)
- Lead sponsor: Hospices Civils de Lyon
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Hospices Civils de Lyon (`cardio:org-hospices-civils-de-lyon`)

## Provenance

Content hash: a30e0a03cc6ecad0b6a71300c5016a28bea6dff2a8ee0265ff09345d871eecc7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
